{'output': [['Guerbet', 'ORG', 'Acquisition', 'Accurate Medical Therapeutics', 'ORG'], ['Accurate Medical Therapeutics', 'ORG', 'Develop', 'Microcatheters', 'PRODUCT'], ['Microcatheters', 'PRODUCT', 'Used_In', 'Interventional Radiology', 'CONCEPT'], ['Accurate Medical Therapeutics', 'ORG', 'Register', 'Products', 'PRODUCT'], ['Accurate Medical Therapeutics', 'ORG', 'Possess', 'Unique Anti-Reflux Technology', 'CONCEPT'], ['Anti-Reflux Technology', 'CONCEPT', 'Make_Possible', 'Administer', 'VERB'], ['Anti-Reflux Technology', 'CONCEPT', 'Prevent', 'Reflux', 'VERB'], ['Interventional Radiology', 'CONCEPT', 'Cover', 'Image-Guided Procedures', 'CONCEPT'], ['Interventional Radiology', 'CONCEPT', 'Include', 'Dilatation of Stenotic Arteries', 'CONCEPT'], ['Interventional Radiology', 'CONCEPT', 'Include', 'Tumor Ablations', 'CONCEPT'], ['Interventional Radiology', 'CONCEPT', 'Include', 'Replacement of Cardiac Valves', 'CONCEPT'], ['Interventional Radiology', 'CONCEPT', 'Include', 'Vertebroplasty', 'CONCEPT'], ['Interventional Radiology', 'CONCEPT', 'Market', 'Several Billion Euros', 'ECON_INDICATOR'], ['Guerbet', 'ORG', 'Target', 'Segment', 'SECTOR'], ['Segment', 'SECTOR', 'Valued', 'About 600 Million Euros', 'ECON_INDICATOR'], ['Segment', 'SECTOR', 'Microcatheters Part', 'Around 120 Million Euros', 'ECON_INDICATOR'], ['Microcatheters Part', 'ECON_INDICATOR', 'Grow', 'Annual Rate of 5% to 10%', 'ECON_INDICATOR'], ['Guerbet', 'ORG', 'Fuel', 'Growth', 'CONCEPT'], ['Guerbet', 'ORG', 'Acquire', '100%', 'PERCENT', 'Accurate Medical Therapeutics', 'ORG'], ['Accurate Medical Therapeutics', 'ORG', 'Retain', 'Structure', 'NONE', 'Israel', 'GPE'], ['Accurate Medical Therapeutics', 'ORG', 'Led_By', 'Inventor', 'PERSON'], ['Guerbet', 'ORG', 'Generate', 'Sales', 'NONE', 'End of this year', 'TIME'], ['Guerbet', 'ORG', 'Accretive', '4th Quarter of 2019', 'TIME'], ['Guerbet', 'ORG', 'Listed', 'Euronext Paris', 'EXCHANGE'], ['Guerbet', 'ORG', 'Generated', '776 Million Euros', 'ECON_INDICATOR', 'Revenue', 'NONE', '2016', 'TIME']]}